These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12728403)

  • 1. Radioimmunotherapy for non-Hodgkin's lymphomas: a historical perspective.
    Press OW
    Semin Oncol; 2003 Apr; 30(2 Suppl 4):10-21. PubMed ID: 12728403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for the management of non-Hodgkin's lymphomas with monoclonal antibodies and immunoconjugates.
    Press OW
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S19-26. PubMed ID: 9672771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monoclonal antibody therapy for malignant lymphoma].
    Buske C; Dreyling M; Unterhalt M; Hiddemann W
    Med Klin (Munich); 2005 Jan; 100(1):14-24. PubMed ID: 15654538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of radioimmunoconjugates in stem cell transplantation.
    Pagel JM; Matthews DC; Appelbaum FR; Bernstein ID; Press OW
    Bone Marrow Transplant; 2002 May; 29(10):807-16. PubMed ID: 12058230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapeutic approaches to non-Hodgkin's lymphomas.
    Lambert JF; Elfenbein GJ
    Med Health R I; 2003 Aug; 86(8):236-9. PubMed ID: 14582217
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
    Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I to III trials of anti-B cell therapy in non-Hodgkin's lymphoma.
    Martin P; Furman RR; Coleman M; Leonard JP
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5636s-5642s. PubMed ID: 17875800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunotherapy of relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
    Dillman RO
    Curr Hematol Rep; 2003 Jan; 2(1):30-7. PubMed ID: 12901152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
    DeNardo GL
    Semin Nucl Med; 2005 Jul; 35(3):202-11. PubMed ID: 16098294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab.
    Lindén O; Hindorf C; Cavallin-Ståhl E; Wegener WA; Goldenberg DM; Horne H; Ohlsson T; Stenberg L; Strand SE; Tennvall J
    Clin Cancer Res; 2005 Jul; 11(14):5215-22. PubMed ID: 16033839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunotherapy of the Non-Hodgkin's Lymphomas.
    Knox SJ
    Semin Radiat Oncol; 1995 Oct; 5(4):331-341. PubMed ID: 10717155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted antibodies in the treatment of lymphomas.
    Falini B; Terenzi A; Liso A; Flenghi L; Solinas A; Pasqualucci L
    Cancer Surv; 1997; 30():295-309. PubMed ID: 9547998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radioimmunotherapy of lymphomas and leukemias].
    Rain JD; Billotey C
    Pathol Biol (Paris); 1998 May; 46(5):341-5. PubMed ID: 9769896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
    Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
    Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
    Sharkey RM; Karacay H; Johnson CR; Litwin S; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
    J Nucl Med; 2009 Mar; 50(3):444-53. PubMed ID: 19223402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunotherapy with monoclonal antibodies. A new horizon in nuclear medicine therapy?
    Sautter-Bihl ML; Bihl H
    Nuklearmedizin; 1994 Aug; 33(4):167-73. PubMed ID: 7971292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiolabeled antibodies for cancer treatment].
    Barbet J; Chatal JF; Kraeber-Bodéré F
    Med Sci (Paris); 2009 Dec; 25(12):1039-45. PubMed ID: 20035676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines.
    Maloney DG
    J Clin Oncol; 2005 Sep; 23(26):6421-8. PubMed ID: 16155029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretargeted radioimmunotherapy for B-cell lymphomas.
    Green DJ; Pagel JM; Pantelias A; Hedin N; Lin Y; Wilbur DS; Gopal A; Hamlin DK; Press OW
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5598s-5603s. PubMed ID: 17875795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.